RSS

development

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. more

Opinion

Global drug discovery and development services company, Crown Bioscience, has extended its existing portfolio of humanised drug target models (HuGEMM) to its San Diego facility. more

News

Zai Lab and Crescendo Biologics have entered a worldwide licensing agreement for the development, commercialisation and manufacture of innovative protein therapeutics for inflammatory indications. more

News

Drug research and development is often likened to finding a needle in a haystack with multiple targets and many potential variables with which they can interact. So, what technological advancements are impacting development timelines… more

Opinion

A strategy for the development of a biosimilar to the vascular endothelial growth factor (VEGF) inhibitor treatment for various degenerative retinal diseases, aflibercept, has been announced by Momenta Pharmaceuticals and Mylan. more

News

Contract packaging and clinical supply services company, Sharp — a part of UDG Healthcare, has revealed it has completed the first phase in the development of its new $23 million clinical services facility in Bethlehem, Pennsylvania, USA. more

News

Capsugel, now a Lonza company, has expanded the clinical trial capabilities, as well as increased development and manufacturing capabilities for specialised drug products using liquid-filled hard capsule (LFHC) technology, at its Edinburgh facility. more

News

Contract development and manufacturing organisation (CDMO) — Recipharm and Kancera, a development company focused on cancer therapy, have entered into a contract for the development and manufacture of the pharmaceutical candidate KAND567. more

News

A new package of support worth up to £86 million is set to benefit companies across the UK for the development of medicines and technologies to help patients being treated through the NHS. more

News

AMRI has been recognised for its excellence as a CMO and has been honoured as part of the Life Science Leader’s 2017 CMO Leadership Awards in five categories — capabilities, compatibility, expertise, quality and reliability. more

News

Johnson Matthey recently expanded its Cambridge facility to add process development and small-scale manufacturing capabilities. Brian Fairley and Antonio Zanotti-Gerosa explain how this will benefit pharmaceutical manufacturing more

Opinion

Mark Egerton, CEO, Quotient Clinical, discusses reformulation drug development services for a changing market more

Opinion

The Swiss Federal Institute of Technology in Lausanne (EPFL) and Pierre Fabre Médicament (PFM) have teamed up to study the use of biosensor chips in the clinical development of drugs more

News

Without competent researchers, innovation processes in European medicines development will not be sustainable, say Klaus Wassermann and Christa Janko, EMTRAIN more

Opinion 1 Comments

Recipharm has bought OnTarget Chemistry, a CRO in Uppsala, Sweden, that specialises in medicinal chemistry, offering synthesis and analytical services that include rare and demanding specialties. more

News

Drug development company Redx Pharma has confirmed the launch of a research and development centre focused on disorders of the immune system. more

News

Bayer has entered into a global agreement with Orion to develop and commercialise the compound ODM-201. more

MediCity, a new centre that will nurture the new generation of healthcare innovators, has opened for business at the Nottingham Enterprise Zone. more

Technology

Already a world leader in custom nucleic acid synthesis, Integrated DNA Technologies (IDT) has expanded its manufacturing capabilities to Singapore. IDT is now able to provide locally-manufactured oligonucleotides to researchers in Singapore and... more

Technology